Skip to main content

Glycopyrrolate

NDC 68083-379 · Gland Pharma Limited

Generic nameGlycopyrrolate
Dosage formINJECTION
RouteINTRAMUSCULAR, INTRAVENOUS
Active ingredient(s)GLYCOPYRROLATE
Strength.2 mg/mL
Pharmacologic classAnticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]
Marketing categoryANDA

Packages

68083-379-10 — 10 VIAL in 1 CARTON (68083-379-10) / 20 mL in 1 VIAL (68083-379-01)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

65145-104 — Glycopyrrolate, 65145-105 — Glycopyrrolate, 65219-801 — Glycopyrrolate, 66794-202 — Glycopyrrolate, 66794-203 — Glycopyrrolate, 66794-204 — Glycopyrrolate, 66794-205 — Glycopyrrolate, 68083-376 — Glycopyrrolate, 68083-377 — Glycopyrrolate, 68083-378 — Glycopyrrolate, 68094-073 — Glycopyrrolate, 69076-475 — GLYCOPYRROLATE, 69076-476 — GLYCOPYRROLATE, 69315-139 — Glycopyrrolate, 69315-140 — Glycopyrrolate, 69452-406 — glycopyrrolate, 70010-106 — Glycopyrrolate, 70069-011 — Glycopyrrolate, 70069-012 — Glycopyrrolate, 70069-013 — Glycopyrrolate, +177 more

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources